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Engineering microbial fatty acid metabolism for biofuels
and biochemicals
Eko Roy Marella1, Carina Holkenbrink1,
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Traditional oleochemical industry chemically processes animal
fats and plant oils to produce detergents, lubricants, biodiesel,
plastics, coatings, and other products. Biotechnology offers an
alternative process, where the same oleochemicals can be
produced from abundant biomass feedstocks using microbial
catalysis. This review summarizes the recent advances in the
engineering of microbial metabolism for production of fatty
acid-derived products. We highlight the efforts in engineering
the central carbon metabolism, redox metabolism, controlling
the chain length of the products, and obtaining metabolites with
different functionalities. The prospects of commercializing
microbial oleochemicals are also discussed.
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Introduction
Oleochemicals are a large group of fatty-acid derived
compounds with an unprecedented application range:
biodiesel, detergents, soaps, personal care products,
industrial lubricants, plastic enhancers, bioplastics, emul-
sifiers, coatings, food and feed additives, and others [1].
Oleochemicals have traditionally been derived from veg-
etable oils and animal fats via chemical or enzymatic
processes [2,3]. However, the limited availability, sus-
tainability, and high cost of feedstocks limit the growth of
this sector [4]. The long-term solution for this problem is
sought in the expansion of feedstock range to more
abundant lignocellulosic biomass [5] and its conversion
via chemical and microbial.
Using a microbial chassis in comparison to the traditional
conversion of plant oils and animal fats presents a number
of advantages. Firstly, feedstock availability is expanded
from edible plant oils and animal fats to abundant first-
generation and second-generation biomass feedstocks.
Secondly, the feedstock-product dependence is elimi-
nated as the desired oleochemicals can be obtained
directly using an engineered cell factory from any feed-
stock, that is, a feedstock can be chosen based on the
market price and availability. Finally, complex oleochem-
icals that cannot be obtained from natural sources because
of low abundance can be produced by introducing novel
synthetic biochemical pathways into platform chassis.
Microbial chassis must be extensively engineered in order
to produce oleochemicals at high titer, rate, and yield for
commercial exploitation [6]. The supply of metabolic
precursors, acyl-CoAs, and redox co-factor NADPH need
to be boosted (Figure 1). The chain length of the products
needs to be controlled to obtain the required properties.
One must also implement heterologous enzymes that will
functionalize fatty acyl-CoAs into final products: hydrox-
ylated and desaturated fatty acids, fatty alcohols, hydro-
carbons, waxes, lactones, and others.
This review highlights the recent advances in the engi-
neering of microbial metabolism towards the optimized
production of natural and synthetic fatty-acid derived
products. The microbial hosts covered in this review
include common industrial workhorses: the bacterium
Escherichia coli, the yeast Saccharomyces cerevisiae, and
the oleaginous yeast Yarrowia lipolytica.
Engineering the central carbon metabolism
A common starting point for engineering microbial hosts is
increasing the supply of fatty acid metabolic precursors:
acetyl-CoA, malonyl-CoA, and fatty acyl-CoAs. In E. coli, it
is effective to limit the fermentative pathways towards
lactate, acetate, succinate, and ethanol, which consume
acetyl-CoA. To circumvent the negative effects of these
deletions on the cellular metabolism, these pathways can be
first downregulated in the production phase, for example,
Wu et al. applied CRISPR-based interference for repression
of fermentative pathways and achieved 36% increase of the
medium-chain fatty acid (MCFA) titer [7] (Table 1).
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Table 1
Metabolic engineering strategies for fatty acid-derived metabolites.
Goals and genetic modificationsa Achievements Host Ref.
Improving acetyl-CoA supply
Inducible #adhE, #pta, #poxB, #ldhA, #frdA) 1.36x C6-C10 FFA titer Ec [7]
Acetate recycling ("acs) 3.71x intracellular AcCoA level Ec [7]
"PCC "MCC 2x FFA Ec [17]
"ADH2, "ALD6, "acsFR 1.6–1.8x FAEE titer Sc [9]
"YlACL, #MLS1, Dgpd1 1.67x FFA titer Sc [11]
ACL route ("MmusACL "RtME "MDH3’ "CTP1) 1.18x FFA titer Sc [10]
PDH-bypass ("ScPDC1 "EcAldH) 1.57x lipid titer Yl [12]
Pyruvate-formate lyase route ("EcPflA "EcPflB) 1.47x lipid titer Yl [12]
Carnitine shuttle ("ScCAT2) 1.75x lipid titer Yl [12]
Non-oxidative PPP ("AnPK "BsPta) 1.62x lipid titer Yl [12]
Increasing acetyl-CoA carboxylase flux
Minimize acyl-CoA pool (Dfaa1 Dfaa4 "MmusTes) 4x ACC transcript level Sc [13]
"ACB1 "ACC1FR 1.2–1.3x FAEE titers Sc [9]
"OLE1 "ACC1 "DGA1 3x lipid yield, 84.7% TM Yl [14]
Chain-length control
RBO ("RtBktB "fadB "EgTER "ydiI) DfadA DtesB 1.1 g/L C6–C10 FFA (SF) Ec [29]
RBO ("RtBktB "fadB "EgTER "ydiI) "acs CRISPRi 3.8 g/L C6–C10 FFA (SF) Ec [7]
RBO ("cytFOX3 "YlKR "YlHTD "cytoETR1 "EcEutE)
CaBdhB
12 mg/L C6–C10 FFA (SF) Sc [30]
FASI replacement ("EcFAS Dfas2 "RcFatB) 54 mg/L C14 (SF) Sc [27]
MPT swapping with Tes 380 mg/L C14 (SF) Yl [12]
FAS mutagenesis 118 mg/L C6–C8 FFA (SF) Sc [23]
Chimeric RtFAS-AcTes ("cRtFAS-AbTes) 1.4 mg/L C6–C8 FFA, 0.3 mg/L C10–C12 FFA (SF) Sc [22]
Product diversificationb
Fatty alcohols (MmarCAR BsSfp EcAHR EcFadD) 2.15 g/L fatty alcohols (FB) Yl [12]
Akanes ("SeFAR "SeADO "SeFd/FNR) 1.31 g/L alkanes (FB) Ec [46]
Alkenes ("JeOleT "HEM3 Dctt3 Dcta Dccp1) 3.7 mg/L (FB) Ec [47]
FAEEs (ER-localized AbAtfA) 136 mg/L (SF) Yl [12]
Linoleic acid (Fvd12) 1.3 g/L (SF) Rt [51]
GLA ("Mald6) 71.6 mg/L (SF) Yl [35]
EPA ("heterologous-C16/C18E, d12, d9, d8, d5, d17) >25% DCW Yl [36,37]
VLC-WE (Delo3 "ELO2 "MaqFAR "SciWS "ACC1FR) 15 mg/L VLC-WE (SF) Sc [48]
CBL lipid (cocoa GPAT, LPAT, and DGAT) Titer not mentioned Sc [38]
HFA (DfadD "ACC "Tes’ "BmCYP102AI) 58.7 mg/L HFA (SF) Ec [40]
Methyl ketones ("RtFAS-ShMks2 "ShMks1) 10 mg/gDCW (SF) Sc [22]
Diacids (RBO, "PpAlkBGT "AcChnD "AcChnE) 0.5 g/L C6–C10 diacids (SF) Ec [29]
Docosanol (Delo3 "ELO1,2 "ACC1FR "AtFAR "MvFAS) 83.5 mg/L (SF) Sc [24]
Compartmentalization
Per-AbAtfA or ER-AbAtfA 15x- (ER) to 19x- (Per) FAEE titer Yl [12]
ER-AbFAR and ER-PmADO 5.3x alkane titer Yl [12]
Per-MaqFAR 2.2x fatty alcohol titer Yl [12]
Per-MmarCAR, Per-SeADO, and Per-SeFd/FNR 1.9x alkanes titer Sc [31]
Redox and cofactor engineering
Increasing NADPH supply ("CaGapC "McMCE2) 99 g/L lipid titer (FB, 98% TM) Yl [19]
The use of compatible Fd/FNR for ADO 1.7x alkane titer Ec [46]
JeOleT cofactor supply ("HEM3 Dctt3 Dcta Dccp) 1.2x alkene titer Sc [47]
The listed examples report the highest titers for corresponding products within the reviewed publications. Symbols and prefixes — ‘"’: over-
expression; ‘#’: downregulation; ‘D’: deletion; cyto: cytosol-localized; ‘0’: truncated version. General abbreviations — CRISPRi: CRISPR-based
interference; SF: shake-flask; FB: fed-batch bioreactor; DCW: dry-cell weight. Species abbreviations — Ab: Acinetobacter baylyi; Ac: Acineto-
bacter sp.; An: Aspergillus nidulans; Bm: Bacillus megaterium; Bs: Bacillus subtilis; Ca: Clostridium acetobutylicum; Ec: E. coli; Eg: Euglena gracilis;
Fv: Fusarium verticillioides; Je: Jeotgalicoccus sp.; Mal: Mortierella alpina; Maq: Marinobacter aquaeolei; Mc: Mucor circinelloides; Mmar:
Mycobacterium marinum; Mmus: Mus musculus; Mv: Mycobacterium vaccae; Pm: Prochlorococcus marinus; Pp: Pseudomonas putida; Rc: Ricinus
communis; Rt: R. toruloides; Sci: Simmondsia chinensis; Se: Synechococcus elongatus; Sh: Solanum habrochaites; Yl: Y. lipolytica. Gene/Enzyme
abbreviations — ACC: acetyl-CoA carboxylase; ADO: fatty-aldehyde deformylating oxygenase; AHR: aldehyde reductase; CAR: carboxylic acid
reductase; C16/C18E: elongase converting palmitate (C16) to stearate (C18); d5, d8, d9, d12, d17: D5-desaturase, D8-desaturase, D9-desaturase,
D12-desaturase, D17-desaturase, respectively; DGAT: diacylglycerol O-acyltransferase; FAR: fatty acyl-CoA- or fatty acyl-ACP reductase; FAS:
fatty-acid synthase; Fd/FNR: ferredoxin and ferredoxin/NADP+ reductase; GPAT: glyceryl-3-phosphate acyltransferase; HTD: b-hydroxyacyl-CoA
dehydratase; KR: b-ketoacyl-reductase; LPAT: lysophosphatidate acyltransferase; ME: malic enzyme; Sfp: phosphopantetheinyl transferase; TER:
trans-b-enoyl-CoA reductase; Tes: thioesterase; WS: wax-ester synthase. Product abbreviations — FAEE: fatty-acid ethyl esters; FFA: free fatty
acids; HFA: hydroxylated fatty-acids; PK: phosphoketolase; VLC-WE: very-long-chain wax ester.
a Unless indicated by a two-letter prefix of the species’ name, the genes are native versions.
b Except for GLA and EPA, only examples using minimal medium were considered.
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The yeast S. cerevisiae does not naturally produce cytosolic
acetyl-CoA at high levels and, to overcome this limitation,
strategies circumventing the native pyruvate dehydroge-
nase reaction have been developed previously [8,9].
Recent studies reported the implementation of cytosolic
acetyl-CoA generation via heterologous ATP:citrate lyase
(ACL). Zhou et al. [10] optimized a synthetic chimeric
citrate lyase pathway by combining the expression of
ATP:citrate lyase from Mus musculus, malic enzyme from
Rhodosporidium toruloides, and overexpression of native
mitochondrial citrate transporter and malate dehydroge-
nase, thus obtaining a 20% increase in the free fatty acid
titer in S. cerevisiae. A strain that was additionally engi-
neered for decreased degradation and activation of fatty
acids and overexpression of acetyl-CoA carboxylase and
fatty acid synthase, produced 1 g/L and 10.4 g/L of free
fatty acids in correspondingly shake flask and fed-batch
cultivations, the highest titers reported to date. A similar
strategy, though using the ATP:citrate lyase from Y.
lipolytica, was applied by Ghosh et al. [11] and resulted
in a small improvement of the free fatty acid titer by 5%.
The authors further carried out 13C metabolic flux analy-
sis and identified that a large flux of acetyl-CoA was
channeled into malate via malate synthase (Mls1p) and
that additional carbon was lost to glycerol via glycerol-3-
phosphate dehydrogenase (Gpd1p). Downregulation of
MLS1 and deletion of GPD1 in addition to ACL over-
expression, resulted in a 70% improvement over the
reference strain, achieving 0.8 g/L of free fatty acids
in shake flasks.
The oleaginous yeast Y. lipolytica has a natural capacity of
high-level production of cytosolic acetyl-CoA, particu-
larly under nitrogen limitation when storage lipids are
accumulated. To enable enhanced biosynthesis of oleo-
chemicals already in the growth phase and to shorten the
fermentation time, Xu et al. overexpressed several alter-
native routes towards acetyl-CoA formation [12]. As
expected, overexpression of native ACL resulted in only
a minor increase in lipid titer, but most of other strategies
led to a significant improvement. Particularly, overexpres-
sion of carnitine acetyltransferase for enhanced export of
mitochondrial acetyl-CoA into the cytosol led to a 75%
improvement of the lipid titer. Moreover, the engineered
strain began accumulating lipids already in the exponen-
tial growth phase before nitrogen became limiting. A final
lipids titer of 66.4 g/L with an overall yield of 0.229 g/g
glucose was achieved in a fed-batch cultivation.
Another important control point to increase the supply of
malonyl-CoA is acetyl-CoA carboxylase (ACC), which is
allosterically inhibited by C16-C20 saturated acyl-CoAs.
This inhibition can be alleviated by deletion of fatty acid-
CoA ligases (e.g., FAA1 and FAA4 in S. cerevisiae), which
activate free fatty acids to acyl-CoAs [13]. Such a strategy
is however not viable for production of acyl-CoA-derived
metabolites and here an alternative approach was used by
Qiao et al. [14]. They overexpressed stearoyl-CoA desa-
turase in lipid-producing Y. lipolytica to decrease the
concentration of stearoyl-CoA, the main inhibitor of
ACC. This resulted in a 3-fold increase of the lipid yield,
reaching 84.7% of the theoretical maximum without
growth impairment [14]. Furthermore, through compar-
ative genomic and transcriptomic analysis of lipid-over-
producing strains, Liu et al. [15] identified a mutant
Mga2p regulator, which leads to increased unsaturated
fatty acid biosynthesis and lipid accumulation. Yet
another approach is to apply dynamic regulatory modules
to balance the precursor and product biosynthesis and
avoid inhibition. A 2.1-fold improvement of the free fatty
acid titer was obtained in E. coli with a regulatory circuit
responding to malonyl-CoA concentration by upregulat-
ing either synthesis or consumption [16]. Shin et al.
bypassed the ACC pathway by expressing methylmalo-
nyl-CoA carboxyltransferase and phosphoenolpyruvate
carboxylase, thus increasing the FFA titer about two-
fold [17].
Engineering the redox metabolism
Fatty acid biosynthesis demands NADPH as a reducing
co-factor, for example, 14 NADPH molecules are needed
to produce one molecule of palmitoyl-CoA from acetyl-
CoA. In Y. lipolytica, 13C metabolic flux analysis identified
the oxidative pentose phosphate pathway as the primary
source of NADPH for lipid biosynthesis [18]. However,
generation of 2 NADPH through the pentose phosphate
pathway costs one carbon, affecting the maximum theo-
retical yield. To improve the stoichiometry, Qiao et al.
[19] tested several alternative strategies for NADPH
generation in Y. lipolytica. The best-performing strain
featured expression of NADP+-dependent glyceralde-
hyde 3-phosphate dehydrogenase from Clostridium
acetobutylicum and of malic enzyme from Mucor
circinelloides. The strain produced 99 g/L lipids with
1.2 g/L/h productivity, which to date, is the best produc-
tion performance of a lipid-accumulating microbial strain.
Combining increased NADPH production with upregu-
lation of oxidative stress defense pathways, improved the
lipid yield by 82% and increased productivity by 5-fold.
This strategy also changed the cellular morphology from
pseudohyphae to single cells, which is beneficial for a
large-scale fermentation process [20].
Controlling the chain length of products
Chain length is important for product properties, for
example, gasoline-like and diesel-like biofuels require
short/medium-chain fatty acids (S/MCFAs), waxes
require very long chain (VLC) fatty acids and alcohols.
Some specialty products such as lactone fragrances and
polyunsaturated fatty acids require a precise chain
length. Several methods to control the chain length of
fatty acid products have been reported, including
Engineering microbes for biofuels and biochemicals Marella et al. 41
www.sciencedirect.com Current Opinion in Biotechnology 2018, 50:39–46
engineering of fatty acid synthases, reverse beta-oxida-
tion, and compartmentalization.
Type I fatty acid synthases
Fungal type I fatty acid synthases (FAS I) are large multi-
modular proteins, releasing primarily palmitoyl-CoA.
Due to the compact structure of fungal FAS I, the shorter
acyl-CoA intermediates remain trapped in the enzyme
complex and are not accessible for the cytosolic thioes-
terase. Various heterologous thioesterases have been
overexpressed in Y. lipolytica and S. cerevisiae, and some
smaller-sized thioesterases had an influence on the fatty
acyl-CoA profiles [21,22]. To obtain a better effect, Xu
et al. replaced the malonyl/palmitoyl transferase domain
(MPT) in FAS1 of Y. lipolytica with heterologous thioes-
terases [12]. The resulting hybrid FAS I resulted in a
three-fold increase of C14 acid, up to 29% of the total free
fatty acids. Another approach was undertaken by
Gajewski et al. [23]. They introduced mutations in the
active sites of the b-ketoacyl synthase (KS), acetyl-CoA:
ACP transacetyltransferase (AT), and malonyl/palmitoyl
transferase (MPT) domains. The resulting mutated var-
iants of FAS I produced up to 0.5 g/L of extracellular
short/medium-chain fatty acids (S/MCFA), predomi-
nantly hexanoate and octanoate, which do not occur in
the wild type. Zhu et al. also created chimeras of fungal
FAS I and thioesterases [22]. S. cerevisiae strains expres-
sing a chimera of FAS I of R. toruloides and a thioesterase
of Acinetobacter baylyi produced up to 1.7 mg/L of short/
medium chain fatty acids. This strategy was found super-
ior to the expression of thioesterase in free form or as a C-
terminal fusion to FAS I [22]. The type I FAS from
mycobacteria produces fatty acids of C16–C26 in length
and has been used for the production of very long chain
fatty acids in S. cerevisiae [24].
Type II fatty acid synthases
Bacteria possess a type II fatty acid synthase (FAS II),
which is a protein complex assembled of multiple sub-
units. Through the expression of heterologous chain-
specific thioesterases, the release of acyl-CoAs with a
specific chain length can be achieved. This has been
demonstrated in several studies. Jawed et al. identified
a thioesterase from Bryantella formatexigens that enabled
highly-specific butyric acid production using the native
FAS in E. coli [25]. To enable the specific production of
C7/9 alkanes, Sheppard et al. tested and optimized a
thioesterase from Cuphea hookeriana and successfully pro-
duced octanoate and decanoate in E. coli without detect-
ing other free fatty acids [26].
The success with manipulating the chain-length specific-
ity of type II FAS in bacteria inspired the replacement of
yeast FAS I with bacterial FAS II. In the study by
Fernandez-Moya et al. [27], nine genes encoding enzymes
in E. coli type II FAS were expressed in S. cerevisiae. The
genes could partially compensate for the knock-out of
the native FAS2, albeit the growth was impaired. To alter
the fatty acid chain-length profile, a thioesterase from
Ricinus communis was used instead of tesA. This shifted
chain-length profile of intracellular fatty acids from C18 to
C14 fatty acids.
Reverse beta-oxidation
For each elongation cycle, which extends the acyl-CoA
chain by two carbons, one malonyl-CoA (C3) is required
and a carbon dioxide molecule is released. The biosyn-
thesis of malonyl-CoA from acetyl-CoA requires an ATP
and is hence energetically costly. As a more energy-
efficient route than FAS [28], a reverse b-oxidation
(RBO) pathway that uses acetyl-CoA instead of malo-
nyl-CoA has been employed. Here, the initiation module,
thiolase, and the last step, thioesterase, can be varied to
control the chain length. Clomburg et al. [29] produced
C6–C10 fatty acids by replacing native thiolase and
thioesterase with the variants from Ralstonia eutropha
[29]. Sheppard et al. successfully designed an E. coli strain
that specifically produced pentane via reverse b-oxidation
[26]. A reverse b-oxidation pathway has also been imple-
mented in S. cerevisiae [30].
Compartmentalization
Xu et al. [12] showed that the fatty acid ethyl ester
(FAEE) titer increased 10–15-fold when the esterifying
enzyme was targeted to either the endoplasmic reticulum
or the peroxisomes although a certain extent of product
degradation was observed under peroxisomal localization.
Localization of the alkane synthesis pathway into endo-
plasmic reticulum [12] or peroxisomes [12,31] also
improved the alkane titer, partly because fatty aldehyde
intermediates were isolated from the competing fatty
alcohol biosynthesis [31]. Sheng et al. [32] employed
peroxisomal targeting of FAR to increase the production
of medium chain-length fatty alcohols due to the higher
abundance of acyl-CoA precursors in peroxisomes [32].
Functionalizing fatty acid intermediates into
products
Lipids and specialty fatty acids
Oleaginous organisms can accumulate lipids at over 20%
of the dry biomass and this capacity can be further
increased by metabolic engineering. Oleaginous yeast
Y. lipolytica was engineered by total to produce 85 g/L
lipids with a productivity of 0.73 g/L/h. The relatively
simple strategy comprised a careful selection of the
parental strain, overexpression of heterologous diacylgly-
cerol acyltransferases type 1 and 2, and deletion of the
native lipase regulator TGL3 [33].
The cells can also be engineered to change the profile of
the acyl chains in lipids, for example, to produce lipids
that contain hydroxylated or desaturated fatty acids. Y.
lipolytica has been engineered to accumulate 12-hydroxy-
9-cis-octadecenoic (ricinoleic) acid to 43% of total lipids
42 Energy biotechnology
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with a cellular content of 60 mg/g DW [34]. Ricinoleic
acid is otherwise obtained from castor seeds, which pre-
sents a safety problem due to the ricin toxin. Polyunsatu-
rated fatty acids (PUFAs) are attractive products due to
their health and physiological benefits. Sun et al. engi-
neered Y. lipolytica to accumulate up to 71.6 mg/L of
g-linolenic acid (an omega-6 acid) in lipids [35]. DuPont
developed Y. lipolytica strains, capable of producing eico-
sapentaenoic acid (an omega-3 acid) at >25% DCW
[36,37]. Manipulation of the TAG synthesis pathway
to produce TAGs with specific combinations of acyl
chains enabled the realization of cocoa-butter-like lipid
accumulation in yeast [38,39].
Hydroxy fatty acids can also be produced in free form, for
example, up to 548 mg/L of mixed hydroxylated acids
were produced in E. coli engineered for improved fatty
acid production and expressing the fatty acid hydroxylase
(CYP102A1) from Bacillus megaterium [40].
Fatty alcohols
Fatty alcohols can be generated from fatty acids, fatty
acyl-ACPs or from acyl-CoAs by fatty acid reductases,
which carry out the reduction either to aldehydes or all
the way to alcohols. From fatty aldehydes, fatty alcohols
can be produced relying solely on the endogenous activity
of aldehyde reductase [31,32,41–43] although overex-
pressing either native [10] or heterologous aldehyde
reductases [12] has also been shown to enhance fatty
alcohol production. Deletion of acyl-CoA synthases
[10,44], deletion of acyl-ACP thioesterases [43], and
overexpression of acyl-CoA synthases [12] were
reported to improve fatty alcohol production when car-
boxylic acid reductase (CAR), acyl-ACP-specific fatty
acyl reductase (FAR), and acyl-CoA-specific FAR were
employed, respectively. Deletion of aldehyde reductase,
catalyzing re-oxidation of fatty aldehydes into fatty
acids, was shown to increase the production of fatty
alcohols [31].
Hydrocarbons
By combining fatty acyl reductases with aldehyde dec-
arbonylases, alkanes can be obtained [45]. Cao et al.
produced 1.3 g/L of alkanes in an engineered E. coli
[46]. In S. cerevisiae, peroxisomal localization of alkane
biosynthesis improved the alkanes titer ca. 7-fold,
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resulting in 3.5 mg/L alkanes [31]. In Y. lipolytica, a 5-fold
improvement was observed and the titer of alkanes was at
16.8 mg/L [12]. A proof-of-concept production of
alkenes at 3.7 mg/L, mainly C17 and C19, was also
demonstrated in S. cerevisiae with a heterologous cyto-
chrome P450 fatty acid decarboxylase [47].
Waxes
Microbial synthesis of very-long-chain fatty acids (VCFA)
and their derivatives, with applications ranging from food
to cosmetics [24], has been demonstrated in S. cerevisiae
when using either endogenous long-chain fatty acid
elongases or mycobacterial type I FAS [24,48]. Expres-
sion of FAR capable of using VLCFA led to the produc-
tion of docosanol [24] and jojoba oil-like waxesters [48]
(Figure 1).
Perspectives
Oleochemicals produced by microbial fermentation have
a prospect of contributing to the growth of the s18-billion
global oleochemical market, and on a long run, they may
also substitute many of the petrochemicals and fossil
transportation fuels with a trillion-s-market. However,
with the current favorable policies for the petrochemical
industry, the fermentation-based low-value oleochem-
icals would result in low profit margins even if the
technology for their production were mature. From the
technological maturity standpoint, the Y. lipolytica-based
single-cell oil process developed by the Stephanopoulos
group features the best production metrics, with a titer of
100 g/L and a nearly theoretical yield [19]. Additionally,
engineered utilization of unnatural mineral sources may
allow fermentation at non-sterile conditions [49]. Con-
version of Y. lipolytica lipids with a high content of oleic
acid into biodiesel will, however, require hydrogenation.
Other microbial processes for the production of low-value
oleochemicals, such as hydrocarbons, fatty alcohols, and
esters, are still very far from commercialization point
(Figure 2).
The commercial efforts in the next 5–10 years will likely
focus on high-value specialty oleochemicals. Single cell
oils enriched with polyunsaturated fatty acids (g-linole-
nic, eicosapentaenoic, arachidonic, and docosahexaenoic
acids) have been produced commercially since 90s using
natural oleaginous algae and fungi [50], and recently also
by engineered Y. lipolytica [36] and this market is
expected to grow further. Examples of other attractive
44 Energy biotechnology
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high-value oleochemicals are specialty hydroxylated fatty
acids for food and feed applications, waxes for cosmetics,
lactone fragrances, and others.
Improving the performance metrics of the strains remains
a major hurdle for the emergence of the new processes
and continuous research on metabolic engineering strat-
egies for improved oleochemicals production is a pre-
request for success.
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